CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1965; 15:105-111
doi: 10.3322/canjclin.15.3.105
© 1965 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verwoerdt, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verwoerdt, A.

CA: A Cancer Journal for Clinicians, Vol 15, 105-111, Copyright © 1965 by American Cancer Society


Communication with the Fatally III

Adriaan Verwoerdt M.D.1

1 Assistant Professor of Psychiatry at Duke University School of Medicine, Durham, North Carolina.

In fatally ill patients, the knowledge about imminent death can interfere with the usual processes of anticipation and hope. This stress combined with the impact of the illness can lead to a regression with a concomitant change in the patient's time scale. A regressive time scale is protective in the sense that day-by-day living again affords good prospects and hope. In informing patients about their condition, the real issue is not whether to tell or not to tell, but rather how much to tell and in what manner. This depends on an assessment of the patient's ego strength and age; the presence of denial mechanisms; the nature and the meaning of the illness; the role of the family; factors pertaining to hospitalization and doctor-patient relationship.

The psychophysiologic significance of hope has been discussed. Hopelessness and helplessness can be managed by the therapeutic use of regression; continued palliative treatment; counteracting the adverse effects of hospitalization; anticipating the patient's needs; and finally, by providing an "ego prosthesis."







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1965 by American Cancer Society.